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The association between psychosocial risk factors and retinal microvascular signs was examined in the Multi-
Ethnic Study of Atherosclerosis. Subjects were recruited from Baltimore, Maryland; Chicago, Illinois; Forsyth
County, North Carolina; Los Angeles County, California; New York, New York; and St. Paul, Minnesota. Levels
of depressive symptoms, trait anger, trait anxiety, chronic burdens, emotional support, and cynical distrust were
assessed by questionnaire (from July 2000 to July 2002). Digital retinal images (from August 2002 to January
2004) from 6,147 participants were used to evaluate retinopathy and retinal vascular caliber. After controlling for
potential confounding factors, the authors found that subjects without access to emotional support (Enriched Social
Support Instrument score of <19 vs. 19) had 60% greater odds of retinopathy (odds ratio ¼ 1.6, 95% confidence
interval (CI): 1.3, 2.0). Subjects with high Spielberger trait-anxiety scale scores (22 vs. 14) and subjects with
high depressive symptoms (Center for Epidemiology Studies Depression Scale score, 16 vs. <16) were also
more likely to have retinopathy (odds ratio ¼ 1.4, 95% CI: 1.1, 1.9 and odds ratio ¼ 1.5, 95% CI: 1.2, 1.9),
respectively. In this cross-sectional study, lack of emotional support, increased trait anxiety, and more depressive
symptoms were associated with retinopathy signs, independently of other known risk factors.
anger; anxiety; depression; microvessels; psychology, social; retina; social support
Abbreviations: CI, confidence interval; CRAE, central retinal arteriolar equivalent; CRVE, central retinal venular equivalent;
hsCRP, high-sensitivity C-reactive protein; MESA, Multi-Ethnic Study of Atherosclerosis.
Psychosocial factors, including depressive symptoms,
trait anger, trait anxiety, chronic burdens, lack of emotional
support, and cynical distrust, have acute as well as chronic
effects that may influence cardiovascular disease risk (1–
14). Although these psychosocial factors have been associ-
ated with clinical cardiovascular disease risk, few studies
have examined the associations of psychosocial factors with
markers of microvascular disease, such as retinopathy and
retinal vascular diameters.
Several hypotheses have been proposed to explain the
relation between psychosocial risk factors and clinical car-
diovascular disease risk (15). Psychosocial factors may in-
fluence the hypothalamic-pituitary-adrenal axis and
sympathetic nervous system resulting in acute vascular, he-
mostatic, and metabolic effects. Alternatively, chronic stress
may lead to cardiovascular disease risk by accelerating the
atherosclerotic process or increasing adverse health behav-
iors that in turn increase cardiovascular disease risk. It is
likely that stress from psychosocial factors manifests itself
through multiple pathways and that the same mechanisms
that may lead to cardiovascular disease may also affect the
retinal microvasculature. For example, arterial endothelial
dysfunction (16, 17) and the disturbances in blood-clotting
mechanisms (18, 19) observed with depression may also
lead to endothelial dysfunction and increased risk of small
thrombotic events in the retina.
Microvascular changes in the retina, including retinopa-
thy and decreased retinal arteriolar and increased retinal
venular diameter, are associated with both subclinical and
clinical cardiovascular disease. Retinopathy has been shown











to be a predictor of congestive heart failure (20), stroke (21,
22), mortality (23), and coronary artery calcification (24),
independently of other common cardiovascular risk factors.
Studies suggest that differences in retinal vascular caliber
are associated with current (25–29) or past (29, 30) blood
pressure, incident hypertension (31–33), carotid atheroscle-
rosis (25, 34), incident coronary heart disease (35), incident
stroke (21, 22, 36), cardiovascular mortality (23), magnetic
resonance image-detected cerebral lacunar infarcts, and
white-matter lesions (37). However, much of the variability
in retinal vascular caliber remains to be explained. Gener-
ally, retinal arteriolar narrowing is strongly associated with
hypertension including past levels of blood pressure. Wider
retinal venules are associated with inflammatory markers,
diabetes, obesity, and subclinical and clinical stroke.
We hypothesize that stress from psychosocial factors is
associated with directly observable retinal microvascular
signs, such as retinopathy and decreased retinal arteriole
and increased retinal venular caliber.
MATERIALS AND METHODS
Study population
The Multi-Ethnic Study of Atherosclerosis (MESA) is
a prospective study of adults aged 45–84 years with no history
of clinical cardiovascular disease at baseline (38). Each site
recruited equal numbers of men and women and site-specific
racial and ethnic proportions. Participants defined themselves
as European, African, Hispanic, or Chinese Americans. The
baseline examination (from July 2000 to July 2002) included
6,814 participants: 1,086 from Baltimore, Maryland; 1,164
from Chicago, Illinois; 1,077 from Forsyth County, North
Carolina; 1,319 from Los Angeles County, California;
1,102 from New York, New York; and 1,066 from St. Paul,
Minnesota. Institutional review board approval was granted at
each study site, and a written informed consent was obtained
from each subject.
Retinal photography and retinal microvascular signs
Fundus photography was performed at examination 2
(from August 2002 to January 2004) by using a standardized
protocol (39, 40). Both eyes were photographed by using
a nonmydriatic digital fundus camera while patients were
seated in a darkened room. Two photographic fields (45)
were taken of each eye. Digital images were evaluated at the
University of Wisconsin Ocular Epidemiology Reading
Center (Madison, Wisconsin) by graders masked to partic-
ipant characteristics. Of the 6,237 participants who attended
the second examination, 6,147 had retinal photography
gradable for signs of retinopathy, and 5,979 were suitable
for measurement of retinal vascular caliber.
Retinopathy was considered to be present if any of the
following lesions were detected from either field 1 (centered
on the optic disc) or field 2 (centered on the fovea) of either
eye: microaneurysms, retinal or vitreous hemorrhages, soft
or hard exudates, or intraretinal microvascular abnormali-
ties. Retinopathy was graded by using a standardized pro-
tocol (41).
Retinal vessel caliber is summarized as the average central
retinal arteriolar equivalent (CRAE) and the average central
retinal venular equivalent (CRVE) by using formulas devel-
oped by Hubbard et al. (42) and modified by Knudtson et al.
(43). Retinal vessel size was determined using field 1 images
of the right eye unless retinal vascular caliber could not be
measured, in which case the left eye was used. All arterioles
and venules coursing through an area 0.5–1 disc diameter
from the optic disc margin were measured by using
a computer-based program (42, 44) (IVAN; University of
Wisconsin, Madison, Wisconsin). Previous studies have
shown that correlations of measurements between the right
and left eyes are high (44). Reproducibility of retinal mea-
surements has been reported, with intra- and intergrader intra-
class correlation coefficients ranging from 0.78 to 0.99 (42).
Psychosocial risk factors
Psychosocial risk factors were assessed by using stan-
dardized questionnaires written in English, Spanish, or
Chinese. All questionnaires were administered at the base-
line examination with the exception of cynical distrust,
which was given during examination 2.
Depressive symptoms were assessed by using the Center
for Epidemiology Studies Depression (CES-D) Scale (45).
The scale includes 20 items that survey mood, somatic com-
plaints, interactions with others, and motor functioning (46).
The response values relate severity in terms of days per
week with a score of 0 for ‘‘rarely or none of the time (less
than 1 day)’’ to a score of 3 for ‘‘most of the time (5–7
days).’’ The score was dichotomized at 16, which repre-
sents the screening cutoff for depression (47) and corre-
sponds to someone that has reported at least 6 items to be
frequently present over the course of the previous week or
most of the 20 items to be present for a shorter duration (46).
Spielberger trait anxiety and trait anger were measured by
using 10 anxiety-present and anger-present items, respec-
tively. Each item was given a direct score of 1–4 on the basis
of 1 (‘‘almost never’’), 2 (‘‘sometimes’’), 3 (‘‘often’’), and 4
(‘‘almost always’’). Trait anxiety implies differences be-
tween people in their disposition to respond to stressful
situations with varying amounts of state anxiety. Trait anger
was designed to assess an individual’s disposition to feeling
angry over time (12, 48). Trait scales were chosen over state
scales to better capture the relations that occur over longer
periods of time. The Spielberger trait-anger and trait-anxiety
scale scores were classified as low (from 10 to 14), moderate
(from 15 to 21), and high (from 22 to 40) on the basis of
previously published work using these scales (12, 13).
Ongoing difficulties from 5 domains described as very
stressful events affecting the lives of subjects for more than
6 months were considered chronic burdens. These included
health of self, health of someone close to them, difficulties
with a job or ability to work, and financial strains or diffi-
culties in a relationship with someone close to them. The
Chronic Burden Scale score was categorized into 3 groups
based on scores of 0, 1, or 2 or more ongoing difficulties in
any of the 5 domains (47).
Cynical distrust was based on an 8-item subset of the full
Cook-Medley Hostility Scale (49). These questions reflect
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the subject’s negative view of humankind, depicting others
as unworthy, deceitful, and selfish (50). Binary responses
were scored a ‘‘1’’ each time a subject agreed with the
cynical statement. Scores ranged from 0 to 8 and were cat-
egorized by quartiles. In order to reduce the participant
burden, this questionnaire was administered during exami-
nation 2. Thus, there were 600 subjects who were not in-
cluded and another 47 who were missing 1 or more
responses leaving 6,167 available for analysis.
Criteria for low social support are based on the Enhancing
Recovery in Coronary Heart Disease Patients Study Social
Support Instrument (51). Response categories were modi-
fied to follow a consistent format based on the Medical
Outcomes Study ranging from 1 (‘‘none of the time’’) to 5
(‘‘all of the time’’). There were 6 items regarding the avail-
ability of someone to listen to you, to give advice to you, to
show you love and affection, to help with daily chores, to
provide emotional support, and to confide in. Scores were
dichotomized at 18 indicating a highest risk category for
lack of social support (51).
Baseline measures
Participants underwent an interview and assessment of
cardiovascular risk factors during the course of the study
(38, 52). Variables for this analysis were based on data
collected at the baseline examination. Demographic vari-
ables included age, sex, race/ethnicity (non-Hispanic white,
non-Hispanic African American, Hispanic, and Chinese),
educational level (less than high school, high school/tech-
nical school/associates degree, college or more), income
(<20,000, 20,000–49,000, 50,000 dollars), current occu-
pation (employed, unemployed, retired), and marital status
(married, widowed/divorced/separated, never married). An-
thropometric measures included height and weight mea-
sured with participants wearing light clothing and no
shoes, as well as body mass index calculated as weight
(kg)/height (m)2.
Behavior assessment included alcohol use (current, past/
never), smoking status (never, former, and current), and
physical activity (total metabolic equivalent (MET) min-
utes/week). Physical activity was measured by using a de-
tailed, semiquantitative questionnaire adapted from the
Cross-Cultural Activity Participation Study (38).
Measures of resting blood pressure have been previously
described (52). The average of the last 2 measurements was
used in analysis. Hypertension was defined as systolic blood
pressure of 140 mm Hg, diastolic blood pressure of 90
mm Hg, or current use of antihypertensive medications. Di-
abetes mellitus was defined as fasting glucose of 7.0
mmol/L (126 mg/dL) or a history of use of insulin or oral
hypoglycemic medication. Duration of diabetes was defined
as the self-reported number of years since first use of med-
ication to treat diabetes. Undiagnosed diabetes or no diabe-
tes was classified as having no duration. Questions about
medication use included use of antipsychotic medications,
benzodiazepines, monoamine oxidase inhibitors, peripheral
vasodilators (except dipyridamole), tricyclic antidepressants
(with or without antipsychotics), and vasodilators (mixed
group with or without diuretics).
Serum measures used in this study included plasma total
and high density lipoprotein cholesterol, serum glucose, and
high-sensitivity C-reactive protein (hsCRP). Fasting (>8
hours) blood samples were drawn from participants, and
aliquots were prepared for central analysis and storage at
the University of Vermont and the University of Minnesota
(38). Standardized protocols, described elsewhere (52),
were used for assaying these measures.
Statistical analyses
The percentages of subjects with high levels of psycho-
social characteristics across categories of various sociode-
mographic, behavioral, and health traits are determined and
compared by using a v2 statistic. Many but not all relations
among these sociodemographic, behavioral, and health
traits with CRAE/CRVE or retinopathy have been previ-
ously studied in this cohort (53), except for education, in-
come, occupation, intentional exercise, marital status, and
use of vasodilators or antipsychotic medications. If any of
these measures was independently associated with our out-
comes after adjustment for known risk factors and associ-
ated with our exposures, it was included in the multiple
regression analyses described below. Previously established
risk factors for CRAE and CRVE include fasting serum
glucose, systolic blood pressure, low density lipoprotein
cholesterol and high density lipoprotein cholesterol, smok-
ing status, body mass index, and hsCRP (53). Risk factors
for retinopathy differ from those listed above for CRAE and
CRVE. Risk factors for retinopathy include the presence and
duration of diabetes, fasting serum glucose, hypertension
status, systolic blood pressure, and low density lipoprotein
cholesterol and high density lipoprotein cholesterol (54, 55).
Multiple regression analyses were used to examine our
primary aim. In model 1, we evaluated the association of
each psychosocial risk factor with each specific retinal mi-
crovascular sign, adjusted for age, sex, race/ethnicity, and
study site as potential confounders. In model 2, we adjusted
for the confounders in model 1, known risk factors for
CRAE/CRVE or for retinopathy, and any additional socio-
demographic, behavioral, or health measures identified in
our preliminary analyses described above. The adjustments
included in model 2 vary for retinal vessel caliber and the
presence of retinopathy due to their varying risk factors. In
multiple regression analyses, an F statistic or v2 statistic
with a nominal P < 0.05 was considered significant. For
the associations not judged statistically significant, categor-
ical exposures were treated as continuous, and a test for
linear trend was also performed. Additional testing included
analyses of model 2 stratified by diabetes status and hyper-
tension status. Analyses were performed by using STATA,
release 8, statistical software (StataCorp LP, College Sta-
tion, Texas).
RESULTS
Table 1 contains baseline characteristics of the MESA
cohort showing the associations between selected sociode-
mographic and behavioral measures and the most severe
categories of psychosocial stress. In general, women were
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Table 1. Percentage of High Levels of Psychosocial Characteristics by Selected Demographic and Behavioral Measures, the Multi-Ethnic Study














% P Value % P Value % P Value % P Value % P Value % P Value
Gender
Female 3,601 4.9 14.4 <0.001 16.8 <0.001 13.4 <0.05 20.8 <0.001 34.9 <0.001
Male 3,213 4.4 9.1 8.5 11.7 26.0 25.1
Race
White 2,622 4.0 <0.001 13.1 <0.001 10.6 <0.001 13.3 <0.01 10.7 <0.001 31.3 <0.001
Chinese 803 4.9 13.6 8.2 11.0 28.8 17.6
African American 1,893 3.0 8.6 11.8 10.9 25.8 34.5
Hispanic 1,496 4.6 13.1 20.9 14.5 40.1 30.1
Age, years
45–54 1,947 6.5 <0.001 13.9 <0.001 15.6 <0.001 14.5 <0.05 22.0 39.1 <0.001
55–64 1,885 5.1 11.8 11.9 12.7 22.0 32.1
65–74 2,017 3.8 11.0 11.7 11.3 24.4 24.2
75–84 965 1.6 10.1 11.9 11.4 26.4 21.3
Education
< High school degree 1,225 6.5 <0.001 15.0 <0.001 20.4 <0.001 13.5 49.1 <0.001 26.3 <0.01
High school to
associates degree
3,173 4.1 12.3 13.0 12.7 22.6 31.2
College graduate 2,393 4.4 9.9 8.9 12.0 12.5 31.1
Income, dollars
<20,000 1,560 4.7 <0.001 16.6 <0.001 21.0 <0.001 17.7 <0.001 37.7 <0.001 32.1
20,000–49,000 2,392 5.0 13.2 13.8 14.5 25.7 31.6
50,000 2,589 4.3 7.9 7.5 8.1 12.8 28.8
Smoking
Never 3,418 4.0 <0.001 12.6 <0.01 13.3 <0.001 11.8 <0.001 24.5 <0.001 29.4 <0.001
Former 2,487 4.7 10.3 10.9 11.9 19.9 29.3
Current 887 7.0 14.0 17.0 17.6 28.6 36.6
Body mass index, kg/m2
<18.5 1,952 4.3 12.4 <0.05 11.4 <0.001 12.2 21.0 <0.05 25.2 <0.001
18.5–24.99 2,666 4.3 11.3 12.3 12.7 23.0 28.4
25–29.99 2,945 5.1 11.8 14.3 12.6 25.6 35.2
30 251 7.2 15.3 19.7 15.3 26.4 51.7
Intentional exercise,
MET minutes/week
<106 1,718 6.9 <0.001 14.6 <0.001 16.6 <0.001 15.2 <0.01 30.5 <0.001 33.0 <0.05
106–825 1,688 4.6 12.8 13.2 12.5 23.1 31.1
826–2,025 1,691 3.4 10.3 10.0 10.5 20.5 27.8
2,026 1,698 3.7 9.9 11.7 12.2 19.5 29.1
Abbreviation: CES-D, Center for Epidemiologic Studies Depression; MET, metabolic equivalent.
a P values are for the v2 statistic of the association between each baseline characteristic and grouped exposure.
b High Spielberger trait-anger, 22; moderate, 15–21; low, <15.
c High Spielberger trait-anxiety, 22; moderate, 15–21; low, <15.
d Depressive symptoms, CES-D score 16; no depressive symptoms, CES-D score <16.
e Lack of emotional support, ENRICHD (Enhanced Recovery in Coronary Heart Disease) Social Support Instrument score 18; access to
emotional support, >18.
f High cynical distrust 8-item subset of the full Cook-Medley Hostility Scale, 5; moderate, 3 or 4; low, 1 or 2; none, 0.
g High burdens, 2 ongoing difficulties in the Chronic Burden Scale; moderate, 1; low, 0.
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more likely than men to have high levels of psychosocial
stress. Negative gradients were seen with level of education,
income, age, and physical activity, while positive gradients
were seen with body mass index. Current smokers had high
levels of stress compared with past and never smokers. We
also examined correlations across psychosocial measures
(results not shown). Correlations were moderately high
(r ¼ 0.36–0.64) across 3 of the measures—anxiety, depres-
sion, and lack of emotional support. Chronic burden was
moderately associated with depression (r ¼ 0.38) but not
with any of the other measures. Anger showed its strongest
association with anxiety (r ¼ 0.41). Cynical distrust
showed only small correlations with the other measures.
Table 2 identifies potential new demographic and behav-
ioral risk factors for CRAE and CRVE after adjustment for
the previously identified risk factors including age, gender,
race/ethnicity, systolic blood pressure, cigarette use, fasting
serum glucose, current alcohol consumption, body mass in-
dex, high density lipoprotein cholesterol, low density lipo-
protein cholesterol, and hsCRP. More education and higher
income were independently associated with smaller CRAE
and smaller CRVE. In addition, use of vasodilators was in-
dependently associated with smaller CRAE, and more in-
tentional exercise was independently associated with
smaller CRVE. Current occupation, marital status, and the
use of antipsychotic medications were not associated with
either CRAE or CRVE and were not included in further
analyses. None of these demographic or behavioral mea-
sures was associated with the presence of retinopathy after
adjustment for traditional risk factors including the presence
and duration of diabetes, fasting serum glucose, hyperten-
sion status, systolic blood pressure, and low density lipopro-
tein cholesterol and high density lipoprotein cholesterol.
After adjustment for race/ethnicity, sex, age, and study
site (model 1), higher levels of trait anxiety, lack of emo-
tional support, more chronic burdens, and the presence of
symptoms of depression were associated with the presence
of retinopathy (Table 3). Compared with subjects with high
emotional support, those with low support had 60% greater
odds of retinopathy (odds ratio ¼ 1.6, 95% confidence in-
terval (CI): 1.25, 1.95). Other high-risk groups included
subjects with high trait anxiety compared with low trait
anxiety (odds ratio ¼ 1.4, 95% CI: 1.08, 1.81), subjects
suffering from depressive symptoms (odds ratio ¼ 1.5,
95% CI: 1.15, 1.83) compared with subjects without depres-
sive symptoms, and those subjects suffering from 2 or more
chronic burdens compared with those without any chronic
burdens (odds ratio ¼ 1.3, 95% CI: 1.09, 1.62). In addition,
the odds of retinopathy increased 10% (odds ratio ¼ 1.1,
95% CI: 1.02, 1.19) per increasing level of cynical distrust.
Table 2. Associations of Demographic and Behavioral Risk Factors with CRAE, CRVE, and Retinopathy, the Multi-
Ethnic Study of Atherosclerosis Cohort, 2000–2004
No.
CRAEa CRVEa Retinopathyb







<High school degree 1,225 144.8 (0.53) <0.001 218.6 (0.80) <0.001 1.0
High school to
associates degree
3,173 144.9 (0.29) 215.8 (0.44) 1.0 0.80, 1.33
College graduate 2,393 142.1 (0.31) 210.1 (0.47) 0.9 0.65, 1.16
Income, dollars
<20,000 1,560 144.4 (0.47) <0.05 217.1 (0.71) <0.05 1.0
20,000–49,000 2,392 143.9 (0.33) 214.7 (0.50) 0.9 0.70, 1.13
50,000 2,589 143.4 (0.3) 211.5 (0.45) 1.0 0.75, 1.28
Intentional exercise,
MET minutes/week
<106 1,718 144.5 (0.42) 217.8 (0.63) <0.01 1.0
106–825 1,688 143.7 (0.4) 213.6 (0.60) 1.1 0.89, 1.45
826–2,025 1,691 143.6 (0.39) 213.4 (0.59) 0.9 0.74, 1.22
2,026 1,698 143.4 (0.38) 211.7 (0.57) 1.0 0.79, 1.30
Use of vasodilators
No 6,493 144 (0.2) <0.05 214.1 (0.31) 1.0
Yes 318 139.5 (0.89) 211.5 (1.35) 0.8 0.56, 1.28
Abbreviations: CRAE, central retinal arteriole equivalent; CRVE, central retinal venule equivalent; MET, metabolic
equivalent; SE, standard error of the mean.
a Adjusted for age, race, sex, study site, systolic blood pressure, serum glucose, smoking status, alcohol use, body
mass index, high density lipoprotein cholesterol, low density lipoprotein cholesterol, and high-sensitivity C-reactive protein.
b Adjusted for the presence and duration of diabetes, fasting serum glucose, hypertension status, systolic blood
pressure, low density lipoprotein cholesterol, and high density lipoprotein cholesterol.
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In model 2, we adjusted for additional independent pred-
icators of retinopathy including duration of diabetes, pres-
ence of diabetes, hypertension or both, systolic blood
pressure, fasting serum glucose, low density lipoprotein
cholesterol, and high density lipoprotein cholesterol. Sub-
jects with high trait anxiety compared with low trait anxiety,
subjects with symptoms of depression versus those without,
and subjects without emotional support compared with
those with emotional support remained at greater odds for
retinopathy (odds ratio ¼ 1.4, 95% CI: 1.11, 1.92; odds


















Low 3,295 10.8 1.0 1.0
Moderate 2,492 11.4 1.1 0.95, 1.34 1.1 0.91, 1.32
High 276 12.0 1.2 0.83, 1.79 1.0 0.69, 1.59
Ptrend 0.12 0.45
Trait anxietye 0.76
Low 2,709 10.6 1.0 1.0
Moderate 2,646 11.0 1.1 0.93, 1.32 1.1 0.91, 1.33
High 700 12.9 1.4 1.08, 1.81 1.4 1.11, 1.92
Ptrend 0.02 0.01
Symptoms of depressionf 0.43
No 5,319 10.7 1.0 1.0
Yes 742 14.0 1.5 1.15, 1.83 1.5 1.16, 1.91
Ptrend 0.002 0.002
Emotional supportg 0.82
Yes 5,299 10.5 1.0 1.0
No 752 14.9 1.6 1.25, 1.95 1.6 1.26, 2.02
Ptrend <0.001 <0.001
Cynical distrusth 0.44
None 1,414 9.3 1.0 1.0
Little 1,704 9.9 1.0 0.80, 1.30 1.0 0.79, 1.32
Moderate 1,507 11.8 1.2 0.91, 1.49 1.1 0.84, 1.41
Severe 1,395 13.6 1.3 1.03, 1.69 1.2 0.89, 1.52
Ptrend 0.02 0.22
Chronic burdensi 0.60
0 2,330 10.6 1.0 1.0
1 1,865 10.0 1.0 0.80, 1.20 1.0 0.78, 1.20
2 1,786 12.6 1.3 1.09, 1.62 1.0 0.87, 1.35
Ptrend 0.008 0.49
Abbreviation: CES-D, Center for Epidemiology Studies Depression.
a Adjusted for age, sex, race/ethnicity, and study site.
b Adjusted for age, sex, race/ethnicity, and study site in model 1 plus the duration and presence of diabetes,
hypertension status, fasting serum glucose, systolic blood pressure, low density lipoprotein cholesterol, and high
density lipoprotein cholesterol.
c P value for the Hosmer-Lemeshow goodness-of-fit test for model 2.
d High Spielberger trait-anger, 22; moderate, 15–21; low, <15.
e High Spielberger trait-anxiety, 22; moderate, 15–21; low, <15.
f Depressive symptoms, CES-D score 16; no depressive symptoms, CES-D score <16.
g Lack of emotional support, ENRICHD (Enhanced Recovery in Coronary Heart Disease) Social Support Instru-
ment score 18; access to emotional support, >18.
h High cynical distrust 8-item subset of the full Cook-Medley Hostility Scale,5; moderate, 3 or 4; low, 1 or 2; none, 0.
i High burdens, 2 ongoing difficulties in the Chronic Burden Scale; moderate, 1; low, 0.
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ratio ¼ 1.5, 95% CI: 1.16, 1.91; and odds ratio ¼ 1.6, 95%
CI: 1.26, 2.02, respectively). Chronic burdens and cynical
distrust were no longer associated with retinopathy after
further adjustment.
We also conducted stratified analyses, first by diabetes
status and then by hypertension status. The prevalence of
retinopathy ranged from 5.8% for subjects with no diabetes
or hypertension to 9.6% for subjects with only hypertension.
Retinopathy was much more common for subjects with di-
abetes; the prevalence of retinopathy was 18.4% for those
with only diabetes and 24.3% if they also had hypertension.
In stratified analyses, associations of depressive symptoms
with the odds of retinopathy were stronger in subjects with-
out diabetes than in those with diabetes (odds ratio ¼ 1.6,
95% CI: 1.17, 2.22 vs. odds ratio ¼ 1.2, 95% CI: 0.84, 1.79,
respectively), or if they had a lack of emotional support
(odds ratio ¼ 1.8, 95% CI: 1.35, 2.46 vs. odds ratio ¼ 1.3,
95% CI: 0.87, 1.84). However, the odds of retinopathy were
greater for subjects with hypertension than those without, if
they had greater symptoms of depression (odds ratio ¼ 1.6,
95% CI: 1.15, 2.19 vs. odds ratio ¼ 1.3, 95% CI: 0.90,
1.92).
There were only a few associations between psychosocial
risk factors and retinal vessel caliber, and most of these
results have not been included. However, trait anger was
associated with CRAE. After adjustment for age, sex,
race/ethnicity, and study site, the mean CRAE was smaller
for subjects with higher levels of trait anger, 143.3 lm
(standard error, 1.02), compared with subjects with low trait
anger, 144.3 lm (standard error, 0.62) (model 1). The dif-
ference in the predicted means did increase slightly in the
fully adjusted model 2. In addition, these results were most
apparent in subjects without diabetes. In this case, the mean
CRAE for subjects with high trait anxiety, 141.9 lm (stan-
dard error, 1.67), was narrower than for subjects with low
trait anxiety, 144.0 lm (standard error, 1.30) (model 2).
Cynical distrust was associated with CRVE. After adjust-
ment for age, race/ethnicity, sex, and study site, subjects
with severe cynical distrust had larger CRVE, 217.9 lm
(standard error, 1.04), than subjects with no cynical distrust,
211.2 lm (standard error, 1.04). After further adjustment
(model 2), this association was no longer statistically
significant although the point estimates were relatively
unchanged.
DISCUSSION
Retinopathy, which includes microaneurysms, hemor-
rhages, and exudates, results from a disruption in the retinal-
blood-brain barrier, necrosis of smooth muscle and endothelial
cells, and retinal ischemia (54, 55). Epidemiologic data sug-
gest that these abnormalities can be found in 2%–14% of the
general nondiabetic population and are fairly common even
in persons without hypertension (56). This was also true in
the MESA cohort where the prevalence of retinopathy was
5.8% for subjects with no diabetes or hypertension, 9.6% for
subjects with only hypertension, 18.4% for those with only
diabetes, and 24.3% if they had both hypertension and
diabetes.
In this study, we have shown that several psychosocial
risk factors are independently associated with the presence
of retinopathy. After adjustment for potential confounders
and known risk factors for retinopathy, a lack of emotional
support was associated with a 60% increase in the odds of
retinopathy for the entire cohort. In addition, subjects with
high trait anxiety compared with low trait anxiety and sub-
jects with depressive symptoms compared with those with-
out had 40% and 50% greater odds of retinopathy,
respectively.
We investigated whether associations of psychosocial
factors with retinopathy differed in persons with and with-
out diabetes or hypertension, 2 conditions known to be
strongly predictive of retinopathy. Heterogeneity in psycho-
social effects could result from greater vulnerability of sub-
jects with diabetes and hypertension due to underlying
vascular damage associated with these conditions. This ap-
peared to be the case for symptoms of depression, which had
a stronger association with retinopathy in subjects with hy-
pertension compared with those without, 60% versus 30%
greater odds of retinopathy. It is also possible that psycho-
social effects may more easily be detected in persons with-
out the presence of these strong predictors of retinopathy.
This was true of less emotional support and symptoms of
depression, which had stronger associations with retinopa-
thy in subjects without diabetes than in those with diabetes
(80% vs. 30% and 60% vs. 20% greater odds of retinopathy,
respectively). However, tests of heterogeneity for these in-
teractions did not reach statistical significance in the entire
cohort.
The focus of our study has been to determine if associa-
tions exist between measures of psychosocial stress and
microvascular signs in the retina. Future studies will be
needed to replicate our findings. Because of the correlated
nature of some psychosocial measures, it is possible that 1
or 2 of these factors may adequately summarize our find-
ings. Additionally, a better examination of possible effect
modifiers in the relation between psychosocial factors and
retinopathy is needed to rule out the possibility that results
from our stratified analyses represent chance findings.
The association between the psychosocial risk factors in-
cluding lack of emotional support, high trait anxiety, and
symptoms of depression with retinopathy raises questions
into possible biologic mechanisms through which these
stressors may ultimately lead to retinopathy and possibly
other clinical conditions including cardiovascular disease.
Because these findings appear independently of diabetes and
hypertension status, they may not be operating entirely
through these pathways. We hypothesize that enduring ef-
fects of psychosocial stress on hemodynamic, vasoconstric-
tive, and hemostatic forces may lead to endothelial
dysfunction or increased risk of small thrombotic events
in the retina. Alternatively, these stressors may lead to ret-
inopathy through increased adverse health behaviors for
these participants such as noncompliance with taking pre-
scribed blood pressure medication (15).
To our knowledge, this is the most extensive investigation
of the relation between psychosocial risk factors and retinal
microvascular signs. In one previous paper from the Cardio-
vascular Health Study (57), no association was found
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between retinal microvascular abnormalities and depressive
symptoms in people aged 70 years or older. However, the
MESA was much larger than the previous study, used the
full version of the Center for Epidemiology Studies Depres-
sion Scale compared with the modified version in the Car-
diovascular Health Study, included photographs of both
eyes compared with 1 eye in the Cardiovascular Health
Study, and studied a younger cohort.
Although our study has shown several associations with
retinopathy but very few associations with retinal vessel
caliber, this is not entirely unexpected. Retinopathy is a more
severe sign of hypertensive retinal vascular damage, is more
reliably measured, is associated pathologically with break-
down of the retinal-blood-brain-barrier and retinal hypoxia,
and is a stronger predictor of stroke, cognitive impairment,
renal dysfunction, congestive heart failure, and cardiovas-
cular disease mortality than other retinal signs such as blood
vessel diameter (54, 55).
Our study does have some limitations. We examined as-
sociations between multiple exposures and outcomes in-
creasing the probability of chance findings. This was
a cross-sectional analysis, so we could not examine the tem-
poral relations of psychosocial factors with retinal micro-
vascular signs. The MESA population represents a cohort
with no history of cardiovascular disease, so our findings
may not generalize to the population as a whole. It is likely
that model 1 is underadjusted and that model 2 is overad-
justed or inappropriately adjusted for our various outcomes.
There are likely multiple pathways through which psycho-
social risk factors may affect retinal microvasculature, and
adjustment for systolic blood pressure, fasting glucose, high
density lipoprotein cholesterol, low density lipoprotein cho-
lesterol, and hsCRP may be inappropriate to the extent that
these may represent pathways through which psychosocial
risk factors may affect retinal microvascular health.
In conclusion, we have shown an association between
lack of emotional support, high trait anxiety, and the pres-
ence of depressive symptoms with retinopathy. These data
suggest that psychosocial factors may have an adverse effect
on the microvasculature. It is not known whether retinopa-
thy associated with these psychosocial factors is a marker
for similar biologic pathways involving the microvascula-
ture in the development of cardiovascular disease.
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